Letters

Neuraminidase inhibitors for influenza A and B

BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7406.105-c (Published 10 July 2003) Cite this as: BMJ 2003;327:105

Antivirals need to be protected from adverse conditions to retain effectiveness

  1. Subhash C Arya, clinical microbiologist (subhashji@hotmail.com),
  2. Nirmala Agarwal, chief, obstetrics and gynaecology
  1. Sant Parmanand Hospital, 18 Alipore Road, Delhi 110054, India

    EDITOR–Cooper et al outlined the role of neurominadase inhibitors in prophylaxis against and treatment of influenza.1 These agents would be important during the early phase of any outbreak of influenza. Nevertheless, their efficacy would be reduced if …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe